EMA News Analysis
🇪🇺 EMAExpert commentary and market intelligence for pharma strategy teams
Showing 1–12 of 34 articles
New EU Template for Clinical Trial Recruitment and Informed Consent: What Pharma Teams Need to Know
Moderna Stock Rises as EMA Committee Backs New RSV Vaccine: Key Implications for Investors and BD Teams
From Approval to Access: Europe’s Next Health Imperative for Pharma
Lilly to Spotlight Growing Hematology Portfolio at 2026 EHA Annual Meeting: Key Data and Strategic Implications
Pharma People on the Move: Spring 2026 Roundup — Regulatory Updates
Favipiravir Shipment to Europe Signals Hantavirus Preparedness Amidst Cruise Ship Outbreak
EMA's United for Health Initiative at WorldPride 2026
SFEE Highlights Significant Delays in Greek Patient Access to New Medicines
Medscape Education Leverages AI for Hematology at EHA 2026
Oxurion NV Expands GLP-1 and Peptide Research Services Amidst Market Growth
EMA's CHMP Recommends Oral Wegovy Approval, Expanding Obesity Treatment Options in Europe
Medscape's AI Integration in Hematology: A Catalyst for Change at EHA 2026